Term ended Oct 23, 2026 · High confidence
20-year base term ended Sep 27, 2026
Held by Amunix Pharmaceuticals, Inc.
Filed Nov 3, 2010 as application 12/939,120 · Granted Jul 23, 2013
Base term plus 26 days of patent term adjustment (USPTO delay)
Today
Term ended Oct 23, 2026
2006
2026
Clock starts
Sep 27, 2006
Sep 27, 2006
Term ended
Oct 23, 2026
Oct 23, 2026
Granted
Jul 23, 2013
Jul 23, 2013
base term
patent term adjustment
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
26
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,855,279, to Oct 23, 2026. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 26 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 27, 2006, when applications 11/528,927 and 11/528,950, the earliest non-provisional applications in its chain, were filed (this one was filed Nov 3, 2010) | Sep 27, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +26 days, USPTO patent term adjustment record | Oct 23, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,855,279) | resolves to Oct 23, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Oct 23, 2026 | High confidence |
This family
| Application 11/528,927 | Abandoned not computed | not computed |
| Application 11/528,950 | Abandoned not computed | not computed |
| US 7,855,279 | In force Aug 2027 | Aug 2027 |
| Application 12/634,556 | Abandoned not computed | not computed |
| US 8,492,530 | this patent Oct 2026 | Oct 2026 |
| Application 13/396,403 | Abandoned not computed | not computed |
| Application 13/439,738 | Abandoned not computed | not computed |
| Application 14/102,297 | Abandoned not computed | not computed |
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 14, 2011 Reel 26128, frame 727 | Schellenberger, Volker; Stemmer, Willem P.; Wang, Chia-wei; Scholle, Michael D.; Popkov, Mikhail; Gordon, Nathaniel C.; Crameri, Andreas | Amunix, Inc. | Assignment of Assignor's Interest |
| Apr 18, 2011 Reel 26142, frame 578 | Amunix, Inc. | Amunix Operating Inc. | Assignment of Assignor's Interest |
| Feb 4, 2021 Reel 55220, frame 810 | Amunix Pharmaceuticals Inc. | National Institutes of Health (Nih), U.S. Dept. of Health and Human Services (DHHS), U.S. Government | Confirmatory License |
| Feb 4, 2021 Reel 55223, frame 978 | Amunix Operating Inc. | Amunix Pharmaceuticals, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Note
The 26 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,855,279, ends no earlier than this term, so it caps nothing.
Citations
32
later US patents cite this one
That is top 25% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.